Lilly Neuroscience International

Thank you to everyone who contributed to #ADPD2026! The conversations once more underscored how collaboration across disciplines moves Alzheimer’s disease research and care forward. Lilly is proud to have supported this event as a Platinum Plus sponsor. See you next year! #AlzheimersAwareness #TimeIsNowAD

We’ll be following Dr. Pablo Martinez-Lage at #ADPD2026 as he explores modifiable risk factors in Alzheimer’s disease and the science behind “Protecting the Brain.” These discussions help prevention research and #AlzheimersAwareness move forward.

At #ADPD2026 in Copenhagen, we’re looking forward to hearing from Assoc. Prof. Matteo Pardini. He discusses how using multimodal profiles for neurodegenerative disorders can sharpen studies in the field, supporting #AlzheimersAwareness.

At #ADPD2026, digital biomarkers are increasingly part of the Alzheimer’s disease conversation - from feasibility to validation and clinical relevance.¹ How can digital biomarkers streamline the pathway of Alzheimer’s disease patients? Share your perspective below.

We’re curious to know what Alzheimer’s disease topic is top of mind for you at ADPD 2026! Vote and specify your reasoning in the comments!

We’re glad to join #ADPD2026 in Copenhagen. Dr. Carole Ho shares her vision on cutting-edge research that accelerates progress for people living with #AlzheimersDisease and those who care for them. #AlzheimersAwareness

As #ADPD2026 brings the community to Copenhagen, prevention remains a key part of the Alzheimer’s disease conversation. How can research, collaboration and real-world implementation move the field forward? Share your perspective in the comments! #TimeIsNowAD

Today is the start of #ADPD2026! We are live in Copenhagen and excited to connect with the community as we explore new insights on mechanisms, prevention, and care in Alzheimer’s disease. What discussions are you looking forward to? Follow us for updates! #AlzheimersAwareness #TimeIsNowAD

Only 1 week until #ADPD2026 begins! Clinicians and scientists from around the world will meet in Copenhagen and online to share data and explore latest developments in Alzheimer’s disease. Which sessions are on your agenda? #AlzheimersAwareness #TimeIsNowAD

On International Women’s Day, we recognize the many ways women shape the Alzheimer’s disease community: as researchers, clinicians, care partners, and people living with the disease.¹,² How can we continue building more inclusive Alzheimer’s disease care pathway?

The Time Is Now to raise the voices of the Alzheimer’s disease (AD) community. At the Alzheimer Europe Conference 2025, we gathered their perspectives on the often long and challenging road to an AD diagnosis.¹ Watch their voices come together in this animation.

2 weeks to go until #ADPD2026 in Copenhagen! This conference brings together the community to discuss advances across #AlzheimersDisease, and related neurological disorders. Lilly is pleased to support as a Platinum Plus sponsor. Will we see you there? #AlzheimersAwareness #TimeIsNowAD

What might define the next generation of Alzheimer’s disease diagnostics? Dr. Ansgar Felbecker discusses how new approaches could influence the evolving diagnostic landscape. Which advances do you consider relevant?

How will Alzheimer’s disease diagnosis evolve in the years ahead? Prof. Jiong Shi explores current challenges and what emerging approaches could mean for future diagnostic pathways. What changes do you see as impactful?

From your perspective, what most limits timely diagnosis of Alzheimer’s disease today? Vote and share your experience in the comments.

Myth or Reality? Are women truly more affected by Alzheimer’s disease? Prof. Audrey Gabelle discusses the evidence behind this claim and its implications for future research. What stories or insights have you encountered about women and Alzheimer’s disease?¹,²

Myth or Reality? Does timely Alzheimer’s disease diagnosis really matter? Dr. Francesco Motolese takes a closer look at this question and what it means for clinical care. In your experience, what most often delays a timely diagnosis?¹,²

Myth or Reality? Could Alzheimer’s disease just be part of “getting older”? Dr. Giulia Giacomucci explores this widespread belief and why recognising deviations from healthy aging is so important. Which changes raise concern in your practice?¹

Hello and happy New Year! As we start 2026, it is important to remember that memory loss is not the only early sign of Alzheimer's Disease¹! Dr. Guido Giuffrè highlights other cognitive changes that should not be overlooked.¹ Watch the video here!

Everyone diagnosed with Alzheimer’s disease deserves timely, coordinated, and personalised care. Yet for many, the post-diagnosis journey remains fragmented. By acting now, we can help ensure the appropriate support reaches each patient in a timely manner.¹,²